BNP Paribas Asset Management
KURA icon

BNP Paribas Asset Management’s Kura Oncology KURA Stock Holding History

BNP Paribas Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,326
Closed -$10.8K – 2303
2026
Q1 		$10.8K Buy
1,326
+563
+74% +$4.84K ﹤0.01% 2196
2025
Q4 		$8K Buy
+763
New +$8.01K ﹤0.01% 2216
2025
Q1 		– Sell
-694,387
Closed -$6.05M – 898
2024
Q4 		$6.05M Buy
+694,387
New +$9.99M 0.02% 523

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

BNP Paribas Asset Management's KURA Position: Q2 2026 in Review

BNP Paribas Asset Management sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 1,326 shares — an estimated $10.8K sold.

BNP Paribas Asset Management first reported a position in KURA in Q4 2024 and held it in 3 quarters. The position peaked at $6.05M in Q4 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • BNP Paribas Asset Management reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 1,326 Kura Oncology shares in Q2 2026, an estimated $10.8K.
  • BNP Paribas Asset Management first reported a position in Kura Oncology in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Asset Management's Kura Oncology position peaked at $6.05M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.